| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jul―12 |
Biotic environment reinforcing the pertinacious clinically relevant COVID-19 associated mucormycosis: First report from Kashmir valley, India |
Insha Amin, Riasa Zaffar, Ruqeya Nazir, Mushtaq Ahmad Rather |
| 2 |
[GO] |
2024―Jan―26 |
Carbapenem-resistant Acinetobacter baumannii strains in the Covid-19 pandemic: 16 S rRNA analysis, carbapenem resistance genes, and antibiotic resistance profiles |
Ömer Acer, Yasemin Genç Bahçe, Osman Özüdoğru |
| 3 |
[GO] |
2023―Dec―07 |
The emergence of a novel SARS-CoV-2 variant with higher efficiency of binding with the human host cell receptors in Iraqi subjects |
Masar R. R. Al-Mousawi, Karar N. J. Musafer, Alaa S. Alattabi, Mohammed Baqur S. Al-Shuhaib |
| 4 |
[GO] |
2023―Mar―27 |
Monitoring SARS-CoV-2 infection in different animal species and human in Egypt during 2020-2021 |
Mohammed A. AboElkhair, Mohamed M. Ahmed, Alaa El Din H. Moustapha, Ali Mohammed Zaki, Rania F. El Naggar, Moustafa Elhamouly, Anis Anis |
| 5 |
[GO] |
2023―Feb―01 |
First molecular detection of SARS-CoV-2 virus in cockroaches |
Mohsen Kalantari, Mozaffar Vahedi, Kourosh Azizi, Amin Hosseinpour, Marzieh Jamalidoust, Hassan Rezanezhad, et al. (+4) Hamzeh Alipour, Mehdi Miri, Negin abolhasanbeigi, Hadi Ashraf |
| 6 |
[GO] |
2022―Aug―09 |
Hypothesized neuroprotective effect of minocycline against COVID-19-induced stroke and neurological dysfunction: possible role of matrix metalloprotease signaling pathway |
Ali Aghajani Shahrivar, Zahra Khakpourian, Fatemeh Majdi, Sarvenaz Sobhani, Natalie Coleman-Fuller, Mina Gholami, Majid Motaghinejad |
| 7 |
[GO] |
2022―Jun―28 |
Recent advances in antiviral effects of probiotics: potential mechanism study in prevention and treatment of SARS-CoV-2 |
Nima Montazeri-Najafabady, Kimia Kazemi, Ahmad Gholami |
| 8 |
[GO] |
2022―Feb―28 |
In silico studies on structural inhibition of SARS-CoV-2 main protease Mpro by major secondary metabolites of Andrographis paniculata and Cinchona officinalis |
Moumita Majumdar, Vishal Singh, Tarun Kumar Misra, Dijendra Nath Roy |
| 9 |
[GO] |
2022―Jan―30 |
Inhibitory efficacy of 2, 4-diacetylphloroglucinol against SARS-COV-2 proteins: in silico study |
Raksha A. Kankariya, Ambalal B. Chaudhari, Navin D. Dandi |
| 10 |
[GO] |
2022―Jan―10 |
Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study |
Sourav Das, Anirudh Singh, Sintu Kumar Samanta, Atanu Singha Roy |
| 11 |
[GO] |
2021―Sep―22 |
In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds |
Laleh Babaeekhou, Maryam Ghane, Mahdi Abbas-Mohammadi |
| 12 |
[GO] |
2021―Aug―17 |
Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations |
Bahareh Vakili, Ashkan Bagheri, Manica Negahdaripour |
| 13 |
[GO] |
2021―Jun―02 |
Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review |
Humna Sajjad, Mohsin Majeed, Saiqa Imtiaz, Mariyam Siddiqah, Anila Sajjad, Misbahud Din, Muhammad Ali |
| 14 |
[GO] |
2020―Oct―15 |
Is a healthy microbiome responsible for lower mortality in COVID-19? |
Lubomír Janda, Matúš Mihalčin, Michaela Šťastná |
